HARMONY BIOSCIENCES HOLDINGS, INC.: diluted earnings per share
Diluted earnings per share for HARMONY BIOSCIENCES HOLDINGS, INC. Inspect selected reporting periods, original units and SEC filing links; download the financial history.
All HARMONY BIOSCIENCES HOLDINGS, INC. financial histories
What this measure means
Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.
Exact concept: us-gaap:EarningsPerShareDiluted. Each value covers an annual-duration reporting interval, shown with both start and end dates. Different units remain separate; no currency conversion or interpolation is applied.
Coverage of this history
Selected reporting periods run from 2019-01-01 to 2025-12-31. The SEC response was captured on 2026-09-19.
Selected filing history
| Period start | Period end | Value | Unit | Filed | Source filing |
|---|---|---|---|---|---|
| 2025-01-01 | 2025-12-31 | 2.71 | USD/shares | 2026-02-24 | 10-K · 0001104659-26-018859 |
| 2024-01-01 | 2024-12-31 | 2.51 | USD/shares | 2026-02-24 | 10-K · 0001104659-26-018859 |
| 2023-01-01 | 2023-12-31 | 2.13 | USD/shares | 2026-02-24 | 10-K · 0001104659-26-018859 |
| 2022-01-01 | 2022-12-31 | 2.97 | USD/shares | 2025-02-25 | 10-K · 0001558370-25-001441 |
| 2021-01-01 | 2021-12-31 | 0.58 | USD/shares | 2024-02-22 | 10-K · 0001558370-24-001466 |
| 2020-01-01 | 2020-12-31 | -2.48 | USD/shares | 2023-02-21 | 10-K · 0001558370-23-001574 |
| 2019-01-01 | 2019-12-31 | -24.07 | USD/shares | 2022-02-28 | 10-K · 0001558370-22-002257 |
Related financial histories
- HARMONY BIOSCIENCES HOLDINGS, INC.: total assets
- HARMONY BIOSCIENCES HOLDINGS, INC.: total liabilities
- HARMONY BIOSCIENCES HOLDINGS, INC.: stockholders equity
- HARMONY BIOSCIENCES HOLDINGS, INC.: cash and cash equivalents
- HARMONY BIOSCIENCES HOLDINGS, INC.: net income or loss
- HARMONY BIOSCIENCES HOLDINGS, INC.: operating cash flow
- HARMONY BIOSCIENCES HOLDINGS, INC.: capital expenditure payments
- HARMONY BIOSCIENCES HOLDINGS, INC.: contract revenue excluding tax
- HARMONY BIOSCIENCES HOLDINGS, INC.: financing cash flow
- HARMONY BIOSCIENCES HOLDINGS, INC.: investing cash flow
- HARMONY BIOSCIENCES HOLDINGS, INC.: retained earnings or deficit
- HARMONY BIOSCIENCES HOLDINGS, INC.: basic weighted-average shares
- HARMONY BIOSCIENCES HOLDINGS, INC.: diluted weighted-average shares
- HARMONY BIOSCIENCES HOLDINGS, INC.: basic earnings per share
- HARMONY BIOSCIENCES HOLDINGS, INC.: income tax expense or benefit
- HARMONY BIOSCIENCES HOLDINGS, INC.: net property, plant and equipment
- HARMONY BIOSCIENCES HOLDINGS, INC.: share-based compensation expense
- HARMONY BIOSCIENCES HOLDINGS, INC.: operating income or loss
- HARMONY BIOSCIENCES HOLDINGS, INC.: current assets
- HARMONY BIOSCIENCES HOLDINGS, INC.: interest expense
- HARMONY BIOSCIENCES HOLDINGS, INC.: current liabilities
- HARMONY BIOSCIENCES HOLDINGS, INC.: current accounts payable
- HARMONY BIOSCIENCES HOLDINGS, INC.: net finite-lived intangible assets
- HARMONY BIOSCIENCES HOLDINGS, INC.: net current accounts receivable
- HARMONY BIOSCIENCES HOLDINGS, INC.: operating expenses
- HARMONY BIOSCIENCES HOLDINGS, INC.: net inventory
- HARMONY BIOSCIENCES HOLDINGS, INC.: gross profit
- HARMONY BIOSCIENCES HOLDINGS, INC.: research and development expense
Inspect the source
- Entity
- HARMONY BIOSCIENCES HOLDINGS, INC. / CIK 0001802665
- Captured
- 2026-09-19T11:21:25.241Z
- SEC response SHA-256
219edd9966de4e2fe15281e20a5bcff1b5a72701848577e42a293ddf6617aa3e
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001802665.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))